Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
49.44
-1.69 (-3.31%)
At close: Sep 15, 2025, 4:00 PM EDT
49.66
+0.22 (0.44%)
After-hours: Sep 15, 2025, 5:50 PM EDT
Cytokinetics Analyst Ratings
Total Analysts
15
Consensus Rating
Buy
Price Target
$75.57
Upside
+52.85%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $53 → $71 | Buy | Maintains | $53 → $71 | +43.61% | Sep 3, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $60 → $80 | Buy | Maintains | $60 → $80 | +61.81% | Sep 3, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $77 → $84 | Strong Buy | Maintains | $77 → $84 | +69.90% | Sep 2, 2025 |
| Stifel | Stifel | Strong Buy Maintains $87 → $96 | Strong Buy | Maintains | $87 → $96 | +94.17% | Sep 2, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $78 | Buy | Reiterates | $78 | +57.77% | Sep 2, 2025 |
| Needham | Needham | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +45.63% | Sep 2, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $80 → $77 | Strong Buy | Maintains | $80 → $77 | +55.74% | Aug 8, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $71 → $53 | Buy | Maintains | $71 → $53 | +7.20% | Jun 9, 2025 |
| Mizuho | Mizuho | Buy Maintains $103 → $84 | Buy | Maintains | $103 → $84 | +69.90% | May 29, 2025 |
| Needham | Needham | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +45.63% | May 14, 2025 |
| Barclays | Barclays | Buy Maintains $55 → $53 | Buy | Maintains | $55 → $53 | +7.20% | May 8, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $82 → $80 | Buy | Maintains | $82 → $80 | +61.81% | May 7, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $86 → $80 | Strong Buy | Maintains | $86 → $80 | +61.81% | May 7, 2025 |
| UBS | UBS | Hold Maintains $47 → $41 | Hold | Maintains | $47 → $41 | -17.07% | May 2, 2025 |
| Needham | Needham | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +45.63% | May 2, 2025 |
| Barclays | Barclays | Buy Initiates $55 | Buy | Initiates | $55 | +11.25% | Apr 24, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.